ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan

Other Plans and Options
  • (-2.53%)Nav, as on 19-03-2026

  • Previous Nav

  • Net Change on 19-03-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option -1.31 -4.79 6.31 28.46 18.81 20.07
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 6.31 28.46 18.81 1.04 6,801.16
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 6.32 24.48 17.20 0.91 8,306.35
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 5.55 26.33 19.06 0.91 4,076.67
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 0.91 22.94 16.31 0.65 3,033.42
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 10.29 26.83 18.36 0.47 2,843.74
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 5.33 24.98 17.50 0.69 1,300.81

Fund Holdings as on 28-February-2026

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Mankind Pharma Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Biocon Ltd.

  • Divi's Laboratories Ltd.

  • Lupin Ltd.

  • Aurobindo Pharma Ltd.

  • Alkem Laboratories Ltd.

  • Syngene International Ltd.

  • Cohance Lifesciences Ltd.

  • Medplus Health Services Ltd

  • TREPS

  • Alivus Life Sciences Ltd.

  • Zydus Lifesciences Ltd.

  • Akums Drugs and Pharmaceuticals Ltd.

  • J.B.Chemicals & Pharmaceuticals Ltd.

  • Thyrocare Technologies Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Gland Pharma Ltd.

  • Entero Healthcare Solutions

  • Pfizer Ltd.

  • Medi Assist Healthcare Services Ltd

  • Blue Jet Healthcare Ltd.

  • Metropolis Healthcare Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Fine Organic Industries Ltd.

  • Hikal Ltd.

  • Anthem Biosciences Ltd

  • Aarti Drugs Ltd.

  • Shilpa Medicare Ltd.

  • Windlas Biotech Ltd.

  • Sanofi Consumer Healthcare India Ltd

  • Astrazeneca Pharma India Ltd.

  • Senores Pharmaceuticals Ltd

  • FDC Ltd.

  • Laxmi Dental Ltd.

  • Nephrocare Health Services Ltd

  • Sun Pharma Advanced Research Co. Ltd

  • Rubicon Research Ltd

  • 91 Days Treasury Bills

  • Cash Margin - Derivatives

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Business Support

  • Hospital & Healthcare Services

  • Retailing

  • Miscellaneous

  • Trading

  • Chemicals

  • Medical Equipment/Supplies/Accessories

View More

  • Cash

  • Equity

  • SOV

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹6,801.16 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended down ₹-1.03(-2.53%)yesterday to ₹39.75.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100